The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes.
Open accessAbstract
Cytotoxic T lymphocytes (CTLs) recognize peptide antigens associated with cell surface major histocompatibility complex (MHC) molecules. The identification of tumor cell-derived peptides capable of eliciting anti-tumor CTL responses would enable the design of antigen-specific immunotherapies. Our strategy to identify such potentially therapeutic peptides relies on selecting high-affinity MHC binders from known tumor-associated antigens. These peptides are subsequently tested for their ability to induce CTLs capable of killing tumor cells. With this strategy, we have identified a nine-residue epitope, derived from the product of the tumor-associated gene MAGE-3, which has the capacity to induce in vitro CTLs that kill melanoma and other tumor cell lines. These results show the primary in vitro induction of tumor-specific human CTLs and illustrate the feasibility of ex vivo antigen-specific approaches to the immunological therapy of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., & Boon, T. (1991) · Science · doi:10.1126/science.1840703 · Cited by 3,545
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
Falk, K., Rötzschke, O., Stevanovié, S., Jung, G., & Rammensee, H.-G. (1991) · Nature · doi:10.1038/351290a0 · Cited by 2,411
Barnstable, C. (1978) · Cell · doi:10.1016/0092-8674(78)90296-9 · Cited by 1,916
A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes
Rosenberg, S. A., Spiess, P., & Lafreniere, R. (1986) · Science · doi:10.1126/science.3489291 · Cited by 1,880
Antigen Recognition by Class I-Restricted T Lymphocytes
Townsend, A., & Bodmer, H. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.003125 · Cited by 1,198
Characterization of Peptides Bound to the Class I MHC Molecule HLA-A2.1 by Mass Spectrometry
Hunt, D. F., Henderson, R. A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., Cox, A. L., Appella, E., & Engelhard, V. H. (1992) · Science · doi:10.1126/science.1546328 · Cited by 1,198
The Biochemistry and Cell Biology of Antigen Processing and Presentation
Germain, R. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.403 · Cited by 1,020
Identification of self peptides bound to purified HLA-B27
Jardetzky, T. S., Lane, W. S., Robinson, R. A., Madden, D. R., & Wiley, D. C. (1991) · Nature · doi:10.1038/353326a0 · Cited by 827
Feltkamp, M. C. W., Smits, H. L., Vierboom, M. P. M., Minnaar, R. P., De Jongh, B. M., Drijfhout, J. W., Schegget, J. T., Melief, C. J. M., & Kast, W. M. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230929 · Cited by 825
Peptides Naturally Presented by MHC Class I Molecules
Rammensee, H. G., Falk, K., & Rötzschke, O. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001241 · Cited by 799
STRUCTURE, FUNCTION, AND DIVERSITY OF CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULES
Bjorkman, P. J., & Parham, P. (1990) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.59.070190.001345 · Cited by 700
Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., & Boon, T. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1453 · Cited by 679
In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine
Deres, K., Schild, H., Wiesmüller, K.-H., Jung, G., & Rammensee, H.-G. (1989) · Nature · doi:10.1038/342561a0 · Cited by 631
Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules
Ruppert, J., Sidney, J., Celis, E., Kubo, R. T., Grey, H. M., & Sette, A. (1993) · Cell · doi:10.1016/0092-8674(93)90472-3 · Cited by 628
Self-citationGreenberg, P. D. (1991) · Advances in Immunology · doi:10.1016/s0065-2776(08)60778-6 · Cited by 603
Yewdell, J. W., & Bennink, J. R. (1992) · Advances in Immunology · doi:10.1016/s0065-2776(08)60875-5 · Cited by 361
Kast, W. M., Roux, L., Curren, J., Blom, H. J., Voordouw, A. C., Meloen, R. H., Kolakofsky, D., & Melief, C. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2283 · Cited by 326
Shimizu, Y., & DeMars, R. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.9.3320 · Cited by 293
Self-citationTumor Eradication by Adoptive Transfer of Cytototic T Lymphocytes
(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60294-8 · Cited by 275
Macatonia, S. E., Taylor, P. M., Knight, S. C., & Askonas, B. A. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1255 · Cited by 258
Houbiers, J. G. A., Nijman, H. W., Van Der Burg, S. H., Drijfhout, J. W., Kenemans, P., Van De Velde, C. J. H., Brand, A., Momburg, F., Kast, W. M., & Melief, C. J. M. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230905 · Cited by 258
Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
Carbone, F. R., & Bevan, M. J. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.3.603 · Cited by 219
Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies
REBAÏ, N., & MALISSEN, B. (1983) · Tissue Antigens · doi:10.1111/j.1399-0039.1983.tb01176.x · Cited by 196
Identifying Strategies for Immune Intervention
Lanzavecchia, A. (1993) · Science · doi:10.1126/science.8493532 · Cited by 192
Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides.
Carbone, F. R., Moore, M. W., Sheil, J. M., & Bevan, M. J. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.6.1767 · Cited by 186
Cell biology of antigen presentation
Neefjes, J. J., & Momburg, F. (1993) · Current Opinion in Immunology · doi:10.1016/0952-7915(93)90077-6 · Cited by 159
Long, E. O., Rosen‐Bronson, S., Karp, D. R., Malnati, M., Sékaly, R., & Jaraquemada, D. (1991) · Human Immunology · doi:10.1016/0198-8859(91)90092-n · Cited by 122
Zakut, R., Topalian, S. L., Kawakami, Y., Mancini, M., Eliyahu, S., & Rosenberg, S. A. (1993) · PubMed · Cited by 62
Cited by
MHC ligands and peptide motifs: first listing
Rammensee, H.-G., Friede, T., & Stevanović, S. (1995) · Immunogenetics · doi:10.1007/bf00172063 · Cited by 1,638
Human tumor antigens recognized by T lymphocytes.
Boon, T., & van der Bruggen, P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.725 · Cited by 842
Van den Eynde, B. J., & van der Bruggen, P. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80050-7 · Cited by 623
Yee, C., Savage, P. A., Lee, P. P., Davis, M. M., & Greenberg, P. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2227 · Cited by 415
Nair, S. K., Boczkowski, D., Morse, M., Cumming, R. I., Lyerly, H. K., & Gilboa, E. (1998) · Nature Biotechnology · doi:10.1038/nbt0498-364 · Cited by 398
Metadata
- Authors
- Celis, E., Tsai, V, Crimi, C., DeMars, R., Wentworth, P. A., Chesnut, R. W., Grey, H. M., Sette, A., & Serra, H. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1994-03-15
- Volume
- 91
- Issue
- 6
- Pages
- 2105-2109
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2009870709
- Cited by
- 306
- References
- 28
- FWCI
- 13.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.